Resorbable Scaffold Promotes Spinal Cord Injury Healing
|
By HospiMedica International staff writers Posted on 14 May 2018 |
|
Image: The Neuro-Spinal scaffold (Photo courtesy of InVivo Therapeutics).
A novel bioresorbable polymer scaffold placed within a spinal cord injury (SCI) site provides structural support to the spared spinal tissue, and a supportive matrix to facilitate endogenous repair processes.
The InVivo Therapeutics (Cambridge, MA, USA) Neuro-Spinal scaffold is a highly porous device designed to mitigate tissue damage resulting from some of the critical patho-physiological events that occur during the acute phase of SCI, including increase in tissue pressure, hemorrhage, and edema. The scaffold is composed of two biocompatible, bioresorbable polymers, Polylactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL), a positively charged polymer conducive to cellular attachment and neurite outgrowth.
The scaffold is trimmed and fitted in the epicenter of the SCI, where it modulates the healing process by providing biocompatible and cellular-adhesive appositional healing, similar to the function of sutures or a butterfly bandage in a skin laceration. It then degrades over several weeks. A study that examined the objective performance of the scaffold in 19 SCI patients showed conversion from complete paraplegia to incomplete injury within six months in 44% of the patients, exceeding the 25% conversion criterion. The study was presented at the American Association of Neurological Surgeons (AANS) annual meeting, held during May 2018 in New Orleans (LA, USA).
“At the time of stabilization surgery, a decompression laminectomy was done at the site of injury and the maximal damage was determined by ultrasonography,” said study presenter Stuart Lee, MD, of Vidant Health (Greenville, NC, USA). “Surgeons exposed the contusion through durotomy/myelotomy, used gentle irrigation to remove the necrotic tissue, and exposed the intramedullary cavity. As a side note, this gave us an opportunity to look at the pathology of acute SCI in humans, something that is generally only possible at autopsy.”
Large, multinational natural history databases consistently indicate that only 12-16% of subjects with complete thoracic injury will convert to an improved American Spinal Injury Association Impairment Scale (AIS) grade by six months after injury.
Related Links:
InVivo Therapeutics
The InVivo Therapeutics (Cambridge, MA, USA) Neuro-Spinal scaffold is a highly porous device designed to mitigate tissue damage resulting from some of the critical patho-physiological events that occur during the acute phase of SCI, including increase in tissue pressure, hemorrhage, and edema. The scaffold is composed of two biocompatible, bioresorbable polymers, Polylactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL), a positively charged polymer conducive to cellular attachment and neurite outgrowth.
The scaffold is trimmed and fitted in the epicenter of the SCI, where it modulates the healing process by providing biocompatible and cellular-adhesive appositional healing, similar to the function of sutures or a butterfly bandage in a skin laceration. It then degrades over several weeks. A study that examined the objective performance of the scaffold in 19 SCI patients showed conversion from complete paraplegia to incomplete injury within six months in 44% of the patients, exceeding the 25% conversion criterion. The study was presented at the American Association of Neurological Surgeons (AANS) annual meeting, held during May 2018 in New Orleans (LA, USA).
“At the time of stabilization surgery, a decompression laminectomy was done at the site of injury and the maximal damage was determined by ultrasonography,” said study presenter Stuart Lee, MD, of Vidant Health (Greenville, NC, USA). “Surgeons exposed the contusion through durotomy/myelotomy, used gentle irrigation to remove the necrotic tissue, and exposed the intramedullary cavity. As a side note, this gave us an opportunity to look at the pathology of acute SCI in humans, something that is generally only possible at autopsy.”
Large, multinational natural history databases consistently indicate that only 12-16% of subjects with complete thoracic injury will convert to an improved American Spinal Injury Association Impairment Scale (AIS) grade by six months after injury.
Related Links:
InVivo Therapeutics
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Desk Aneroid Sphyg
Diagnostix 750D+
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Latest Surgical Techniques News
- Fluorescence Imaging Reveals Nerves Under Normal Operating-Room Lighting
- Programmable Microwave Ablation System Gains CE Mark for Minimally Invasive Tissue Ablation
- Researchers Develop Microbots to Help Drugs Reach Blood Clots
- Minimally Invasive Balloon Procedure May Redirect Blood Flow During Cardiac Arrest
- First Stemless Reverse Shoulder Arthroplasty System Receives FDA Clearance in U.S.
- First U.S. Procedures Successfully Completed With New GERD Implant
- Study Explores 4DCT Ventilation for Preoperative Assessment in Early Lung Cancer
- Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
- FDA Approves First Transcatheter Device for Paravalvular Leak Closure
- Smaller Surgical Margins May Help Protect Healthy Tissue in Young Sarcoma Patients
- BD Launches TIPS Stent Graft for Personalized Portal Hypertension Treatment
- Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma
- FDA-Cleared Thrombectomy System Removes Pulmonary Embolism Clots
- Miniature Image Sensor Enables Digital Imaging in Single-Use Endoscopes
- Transcatheter Repair System Gains FDA Approval for Severe Tricuspid Regurgitation
- Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia
Channels
Artificial Intelligence
view channel
AI Analysis of Smartwatch ECGs May Help Detect Weakened Heart Function
Left ventricular systolic dysfunction (LVSD) occurs when the heart’s main pumping chamber does not contract effectively. The condition can remain asymptomatic for some time but may progress to symptomatic... Read more
AI Tool Speeds Echocardiogram Reporting With Comparable Accuracy
Echocardiography is the most widely used form of cardiac imaging, playing a key role in diagnosing heart disease and guiding treatment decisions. However, reviewing ultrasound images and documenting cardiac... Read more
Critical Care
view channel
Inhaled Therapy Uses Modified Bacteria to Break Down Pseudomonas Biofilms
Biofilms are protective layers of bacteria that can form inside endotracheal tubes during mechanical ventilation, making infections difficult to treat because intravenous antibiotics often struggle to... Read more
Miniature Wearable Sensor Enables Continuous Cuffless Blood Pressure Monitoring
Blood pressure is a key indicator of cardiovascular health, but conventional cuff-based measurement typically provides only a single reading at one point in time. This can limit monitoring during everyday... Read more
Patient Care
view channel
Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery
Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more
Medical Imaging
view channel
Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis
Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more
MRI Test Identifies Candidates for Lower-Dose Radiotherapy in HPV Throat Cancer
Human papillomavirus (HPV)-positive oropharyngeal cancer is a throat cancer linked to HPV infection. Its incidence is rising, and many patients receive high-dose radiotherapy that can cause long-term swallowing... Read more
Health IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Point of Care
view channel
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Business
view channel
Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings
Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
